US OptionsDetailed Quotes
MESO241220C5000
- 3.50
- 0.000.00%
15min DelayClose Nov 26 16:00 ET
0.00High0.00Low
3.50Open3.50Pre Close0 Volume1 Open Interest5.00Strike Price0.00Turnover166.19%IV-23.08%PremiumDec 20, 2024Expiry Date6.05Intrinsic Value100Multiplier23DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9818Delta0.0096Gamma1.81Leverage Ratio-0.0049Theta0.0031Rho1.78Eff Leverage0.0013Vega
Mesoblast Stock Discussion
Sign in to post a comment
$Mesoblast (MESO.US)$ …got approval from FDA??
1
$Mesoblast (MESO.US)$ How low will it go?
1
1
$Mesoblast (MESO.US)$ … today back to 10
1
7
$Mesoblast (MESO.US)$ .. will drop then rocket by end of this year
1
2
$Mesoblast (MESO.US)$
Mesoblast Option to Issue Up to US$50 Million Convertible Notes for Product Launch | MESO Stock News
Mesoblast Option to Issue Up to US$50 Million Convertible Notes for Product Launch | MESO Stock News
1
1
$Mesoblast (MESO.US)$ .. if below to 5.. nice to buy!!!
2
4
$Mesoblast (MESO.US)$ Mesoblast (MESO) has released an update. Mesoblast Limited has resubmitted a Biologics License Application (BLA) to the FDA for Ryoncil®, aiming to treat children with Steroid-Refractory Acute Graft-Versus-Host Disease (SR-aGVHD). The resubmission, buoyed by promising Phase 3 study results demonstrating significant survival benefits, could meet an urgent need for effective treatment in this patient group, as current survival outcomes are poor and no FDA-approved treatm...
2
8
$Mesoblast (MESO.US)$ which is developing off-the-shelf cellular medicines for life-threatening inflammatory conditions, is planning to file a Biologics License Application for Ryoncil with the FDA next week.
2
2
No comment yet
Aariya : may be almost there or already done but not yet published